Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Cryoport, Inc. on February 18, 2011, covering events occurring on February 14 and February 15, 2011. The filing details the completion of a private placement of securities and a change in executive management.
Key Financial Metrics
- Capital Raised (Round 2): Gross proceeds of $4,918,740; estimated net proceeds of approximately $4,344,000 after offering expenses.
- Capital Raised (Round 1): $4.4 million from 6,335,318 units (announced February 7, 2011).
- Use of Proceeds: Working capital purposes.
- Placement Agent Fees: Up to 10% commission plus a 3% non-accountable finance fee of aggregate gross proceeds.
- Debt and Liquidity: The filing text does not provide specific values for existing debt, cash flow, or liquidity ratios.
Material Changes
- Securities Issuance: Issued 7,026,771 units at $0.70 per unit. Each unit consists of one share of Common Stock and one warrant to purchase one share at $0.77 per share (5-year term, immediately exercisable).
- Executive Departure: Michael Bartholomew, Chief Commercialization Officer, resigned effective February 15, 2011. He may consult on specific projects in the future.
- Management Realignment: CEO Larry Stambaugh will assume responsibility for sales and marketing until a replacement is appointed.
Guidance, Outlook, and Risks
- Registration Rights: The company is obligated to file a registration statement with the SEC within 90 days to register the resale of shares and underlying warrants. Failure to do so may trigger payments to investors.
- Unusual Items: The transaction was conducted under exemptions provided by Rule 505/506 of Regulation D and/or Section 4(2) of the Securities Act.
- Outlook: No specific financial guidance or forward-looking projections were provided in this filing.
Investor Verification Checklist
- Verify the total aggregate capital raised from both rounds of the private placement ($8.8 million+).
- Confirm the timeline for the filing of the registration statement required by the Registration Rights Agreement (within 90 days of closing).
- Monitor the appointment of a new Chief Commercialization Officer to replace the resigned executive.
- Review the full text of the Purchase Agreement and Registration Rights Agreement filed as exhibits to the Form 10-K for the fiscal year ended March 31, 2011.